Puig revenues rose 5.6% on a like-for-like basis to €1.39 billion in the third quarter of 2026, the Spanish company said on Wednesday. This follows a 4.7% sales increase in Q1 and a 4.1% uplift in Q2.
“Momentum was broad across business segments and regions,” Puig CEO José Manuel Albesa said in a statement. “Asia-Pacific, niche fragrances, dermocosmetics and makeup were particularly strong, delivering double-digit growth, alongside continued healthy growth in fragrance and fashion.”
José Manuel Albesa, Puig CEO.
Photo: Courtesy of Puig
Fragrance and fashion sales, the lion’s share of the business, grew 3.9% on a like-for-like basis to €985.8 million, notably driven by double-digit growth at niche fragrances and Carolina Herrera. Growth at Rabanne and Jean Paul Gaultier, meanwhile, is normalizing after “doubling or tripling in size in the last five years”, according to CFO Miquel Angel Serra. “In the case of Gaultier, we are also reigniting growth. We just launched La Favorite in key European markets. We will have the global rollout next year, and we are happy with the results. We are in the top 15 with La Favorite in France, which is one of the most difficult markets to penetrate with innovation.”
Makeup, which includes Charlotte Tilbury, grew 16.1% to €269.7 million in the quarter. Skincare sales slipped 0.8% to €135.3 million. While premium skincare remained soft, dermocosmetics grew double digit, driven by Uriage, the group said.
By geography, EMEA (Europe, the Middle East, and Africa) grew 3.8% like-for-like to €727.5 million. The Americas delivered 6.2% growth to €506.7 million, while Asia-Pacific revenues rose 12.9% hitting €156.5 million.
L’Oréal Group is to report its Q3 earnings on Thursday. LVMH’s perfumes and cosmetics division reported a 1% organic sales increase to €2 billion in Q3. Estée Lauder Companies will report its first fiscal quarter on November 2.
During the earnings call on Wednesday, Albesa talked about the acquisition of the remaining 50% of Spanish dermocosmetics brand ISDIN, which was announced on September 14. “ISDIN is a highly attractive brand at the forefront of skincare, photo protection, and photoaging, rooted in medical credibility. It brings a strong track record of growth, innovation, and category leadership. The transaction further strengthens our position in dermocosmetic, a category where we continue to see significant long-term opportunities,” he said.
Albesa added: “Without any doubt, dermocosmetic is going to be the fastest growing segment in skincare in the next year, and we are strongly betting on skincare.”
Puig will present its future roadmap at its Capital Markets Day, scheduled for October 28, in Madrid.
.jpg)
.jpg)
